...
首页> 外文期刊>Indian Journal of Ophthalmology >Surgical outcomes of transconjunctival sutureless 23-gauge vitrectomy with silicone oil injection
【24h】

Surgical outcomes of transconjunctival sutureless 23-gauge vitrectomy with silicone oil injection

机译:硅油注射经结膜无缝23号玻璃体切割术的手术效果

获取原文
           

摘要

AimsTo evaluate the outcomes and complications of 23-gauge transconjunctival sutureless vitrectomy (TSV) with Silicone oil (SO) tamponade in complex vitreoretinal diseases.Settings and DesignEge university hospital ophthalmology department. Retrospective case series.Materials and MethodsForty eyes of 40 patients with diabetic tractional retinal detachment (DTRD) and proliferative vitreoretinopathy (PVR) were included in the study. Vitrectomy using 23-gauge system with SO endotamponade was performed. Peroperative and postoperative complications, anatomical and visual results were evaluated.Statistical analysis usedPaired Student's t-test.ResultsSimultaneous cataract surgery was performed in 17 eyes. Peroperative complications were posterior capsule rupture during phacoemulsification in one patient, vitreous and retinal incarceration in one patient. One eye required suture placement at the end of surgery due to SO leakage. Postoperatively, a small subconjunctival SO bubble in three patients, and hypotony in one patient (6 mmHg) were observed. Recurrent retinal detachment under SO occurred in one patient. Mean follow-up was 6.5 months (±2.7). Pre- and postoperative mean visual acuity was 2.22±0.91 logMAR and 1.11±0.8 logMAR, respectively (P<0.001). Mean intraocular pressure (IOP) on the first postoperative day was lower than preoperative IOP (11.3 ±3.2 versus 14.0 ±2.4 mmHg) (P<0.001).ConclusionsTwenty-three gauge instrumentation seems to be feasible, effective and safe for vitrectomy with SO injection in DTRD and PVR, and can be considered in the surgical management of these complex vitreoretinal diseases.
机译:目的评估在复杂的玻璃体视网膜疾病中使用23号经结膜经缝线无玻璃体玻璃体切割术(TSV)和硅油(SO)填塞术的结果和并发症。地点和设计大学大学医院眼科。回顾性病例系列。材料与方法本研究纳入了40例糖尿病性牵引性视网膜脱离(DTRD)和增生性玻璃体视网膜病变(PVR)患者的40眼。使用带有SO内填塞的23规格系统进行玻璃体切除术。评估围手术期和术后并发症,解剖学和视觉结果。采用统计分析对学生进行t检验。结果17眼同时进行了白内障手术。围手术期并发症是一名患者在超声乳化术中后囊破裂,一名患者的玻璃体和视网膜嵌顿。由于SO泄漏,在手术结束时,一只眼睛需要缝合线。术后观察到3例患者结膜下SO泡小,1例患者低渗(6 mmHg)。 1例患者发生SO下复发性视网膜脱离。平均随访时间为6.5个月(±2.7)。术前和术后平均视力分别为2.22±0.91 logMAR和1.11±0.8 logMAR(P <0.001)。术后第一天的平均眼压(IOP)低于术前的IOP(11.3±3.2 vs 14.0±2.4 mmHg)(P <0.001)。结论二十三号仪器似乎是可行的,有效的和安全的,用于玻璃体切除术的SO注射在DTRD和PVR中使用,并且可以在这些复杂的玻璃体视网膜疾病的手术治疗中考虑。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号